MD
Maryland House Bill HB283

Maryland 2023 Regular Session

Maryland House Bill HB283 Compare Versions

OldNewDifferences
1- WES MOORE, Governor Ch. 253
21
3-– 1 –
4-Chapter 253
5-(House Bill 283)
62
7-AN ACT concerning
3+EXPLANATION: CAPITALS INDICATE MAT TER ADDED TO EXISTIN G LAW.
4+ [Brackets] indicate matter deleted from existing law.
5+ Underlining indicates amendments to bill.
6+ Strike out indicates matter stricken from the bill by amendment or deleted from the law by
7+amendment.
8+ Italics indicate opposite chamber/conference committee amendments.
9+ *hb0283*
810
9-Maryland Medical Assistance Program – Gender–Affirming Treatment
10-(Trans Health Equity Act)
11+HOUSE BILL 283
12+J1 (3lr1095)
13+ENROLLED BILL
14+— Health and Government Operations/Finance —
15+Introduced by Delegates Kaiser, Cullison, Acevero, Allen, Amprey, Atterbeary,
16+Bagnall, B. Barnes, Barve, Boyce, Cardin, Charkoudian, Clippinger,
17+Ebersole, Edelson, Embry, Fair, Feldmark, Fennell, Foley, Forbes,
18+Fraser–Hidalgo, Grossman, Guzzone, Hill, D. Jones, Kaufman, Kelly, Kerr,
19+Lehman, R. Lewis, Lopez, Love, McCaskill, Mireku –North, Moon,
20+Palakovich Carr, Pasteur, Qi, Queen, Reznik, Rosenberg, Ruth, Shetty,
21+Simpson, Smith, Solomon, Stein, Stewart, Taveras, Terrasa, Valderrama,
22+Vogel, Watson, Wells, Wilkins, and Ziegler Ziegler, Pena–Melnyk, White, and
23+Martinez
1124
12-FOR the purpose of requiring, beginning on a certain date, the Maryland Medical
13-Assistance Program to provide medically necessary gender–affirming treatment in a
14-nondiscriminatory manner; requiring that the gender–affirming treatment be
15-assessed according to nondiscriminatory criteria that are consistent with current
16-clinical standards; prohibiting the Program from issuing an adverse benefit
17-determination related to gender–affirming treatment unless a health care provider
18-with experience prescribing or delivering gender–affirming treatment has reviewed
19-and confirmed the appropriateness of the determination; and generally relating to
20-gender–affirming treatment and the Maryland Medical Assistance Program.
25+Read and Examined by Proofreaders:
2126
22-BY repealing and reenacting, without amendments,
23- Article – Health – General
24-Section 15–103(a)(1)
25- Annotated Code of Maryland
26- (2019 Replacement Volume and 2022 Supplement)
27+_______________________________________________
28+Proofreader.
29+_______________________________________________
30+Proofreader.
2731
28-BY repealing and reenacting, with amendments,
29- Article – Health – General
30-Section 15–103(a)(2)(xx) and (xxi)
31- Annotated Code of Maryland
32- (2019 Replacement Volume and 2022 Supplement)
32+Sealed with the Great Seal and presented to the Governor, for his approval this
3333
34-BY adding to
35- Article – Health – General
36-Section 15–103(a)(2)(xxii) and 15–151
37- Annotated Code of Maryland
38- (2019 Replacement Volume and 2022 Supplement)
34+_______ day of _______________ at ________________________ o’clock, ________M.
3935
40- SECTION 1. BE IT ENACTED BY THE GENERAL ASSEMBL Y OF MARYLAND,
41-That the Laws of Maryland read as follows:
36+______________________________________________
37+Speaker.
4238
43-Article – Health – General
39+CHAPTER ______
4440
45-15–103.
41+AN ACT concerning 1
4642
47- (a) (1) The Secretary shall administer the Maryland Medical Assistance
48-Program.
49- Ch. 253 2023 LAWS OF MARYLAND
43+Maryland Medical Assistance Program – Gender–Affirming Treatment 2
44+(Trans Health Equity Act) 3
5045
51-– 2 –
52- (2) The Program:
46+FOR the purpose of requiring, beginning on a certain date, the Maryland Medical 4
47+Assistance Program to provide medically necessary gender–affirming treatment in a 5
48+nondiscriminatory manner; requiring that the gender–affirming treatment be 6
49+assessed according to nondiscriminatory criteria that are consistent with current 7 2 HOUSE BILL 283
5350
54- (xx) Beginning on July 1, 2023, shall provide, subject to federal
55-approval and limitations of the State budget, community violence prevention services in
56-accordance with 15–141.3 of this subtitle; [and]
5751
58- (xxi) Beginning on January 1, 2023, shall provide, subject to the
59-limitations of the State budget, and as permitted by federal law, coverage for self–measured
60-blood pressure monitoring for all Program recipients diagnosed with uncontrolled high
61-blood pressure, including:
52+clinical standards; prohibiting the Program from issuing an adverse benefit 1
53+determination related to gender–affirming treatment unless a health care provider 2
54+with experience prescribing or delivering gender–affirming treatment has reviewed 3
55+and confirmed the appropriateness of the determination; and generally relating to 4
56+gender–affirming treatment and the Maryland Medical Assistance Program. 5
6257
63- 1. The provision of validated home blood pressure monitors;
64-and
58+BY repealing and reenacting, without amendments, 6
59+ Article – Health – General 7
60+Section 15–103(a)(1) 8
61+ Annotated Code of Maryland 9
62+ (2019 Replacement Volume and 2022 Supplement) 10
6563
66- 2. Reimbursement of health care provider and other staff
67-time used for patient training, transmission of blood pressure data, interpretation of blood
68-pressure readings and reporting, and the delivery of co –interventions, including
69-educational materials or classes, behavioral change management, and medication
70-management; AND
64+BY repealing and reenacting, with amendments, 11
65+ Article – Health – General 12
66+Section 15–103(a)(2)(xx) and (xxi) 13
67+ Annotated Code of Maryland 14
68+ (2019 Replacement Volume and 2022 Supplement) 15
7169
72- (XXII) BEGINNING ON JANUARY 1, 2024, SHALL PROVIDE
73-GENDER–AFFIRMING TREATMENT IN ACCORDANCE WITH § 15–151 OF THIS
74-SUBTITLE.
70+BY adding to 16
71+ Article – Health – General 17
72+Section 15–103(a)(2)(xxii) and 15–151 18
73+ Annotated Code of Maryland 19
74+ (2019 Replacement Volume and 2022 Supplement) 20
7575
76-15–151.
76+ SECTION 1. BE IT ENACTED BY THE GENERAL ASSEMBLY OF MARYLAND, 21
77+That the Laws of Maryland read as follows: 22
7778
78- (A) (1) IN THIS SECTION THE FOL LOWING WORDS HAVE TH E MEANINGS
79-INDICATED.
79+Article – Health – General 23
8080
81- (2) (I) “GENDER–AFFIRMING TREATMENT ” MEANS ANY
82-MEDICALLY NECESSARY TREATMENT CONSISTENT WITH CURRENT CLINICA L
83-STANDARDS OF CARE PR ESCRIBED BY A LICENS ED HEALTH CARE PROVI DER FOR
84-THE TREATMENT OF A CONDITION RELAT ED TO THE INDIVIDUAL ’S GENDER
85-IDENTITY.
81+15–103. 24
8682
87- (II) “GENDER–AFFIRMING TREATMENT ” INCLUDES:
83+ (a) (1) The Secretary shall administer the Maryland Medical Assistance 25
84+Program. 26
8885
89- 1. HORMONE THERAPY , HORMONE BLOCKERS , AND
90-PUBERTY BLOCKERS ;
86+ (2) The Program: 27
9187
92- 2. HAIR ALTERATION FOR T HE PURPOSES OF ALTER ING
93-SECONDARY SEX CHARAC TERISTICS AND SURGICAL SITE PREPARATION ;
94- WES MOORE, Governor Ch. 253
88+ (xx) Beginning on July 1, 2023, shall provide, subject to federal 28
89+approval and limitations of the State budget, community violence prevention services in 29
90+accordance with 15–141.3 of this subtitle; [and] 30
9591
96-– 3 –
97- 3. ALTERATIONS TO VOICE , VOICE THERAPY , AND VOICE
98-LESSONS;
92+ (xxi) Beginning on January 1, 2023, shall provide, subject to the 31
93+limitations of the State budget, and as permitted by federal law, coverage for self–measured 32
94+blood pressure monitoring for all Program recipients diagnosed with uncontrolled high 33
95+blood pressure, including: 34
9996
100- 4. ALTERATIONS TO ABDOME N, CHEST, TRUNK, AND
101-BUTTOCKS;
97+ 1. The provision of validated home blood pressure monitors; 35
98+and 36 HOUSE BILL 283 3
10299
103- 5. ALTERATIONS TO THE FACE AND NECK ;
104100
105- 6. ALTERATIONS TO THE GENITALS AND GONADS;
106101
107- 7. LASER TREATMENT FOR S CARS FROM
108-GENDER–AFFIRMING TREATMENT ;
102+ 2. Reimbursement of health care provider and other staff 1
103+time used for patient training, transmission of blood pressure data, interpretation of blood 2
104+pressure readings and reporting, and the delivery of co –interventions, including 3
105+educational materials or classes, behavioral change management, and medication 4
106+management; AND 5
109107
110- 8. STANDARD FERTILITY PR ESERVATION PROCEDURE S,
111-AS SET FORTH IN § 15–810.1 OF THE INSURANCE ARTICLE;
108+ (XXII) BEGINNING ON JANUARY 1, 2024, SHALL PROVIDE 6
109+GENDER–AFFIRMING TREATMENT IN ACCORDANCE WITH § 15–151 OF THIS 7
110+SUBTITLE. 8
112111
113- 9. REVISIONS TO PREVIOUS TREATMENTS AND
114-REVERSAL OF TREATMEN TS;
112+15–151. 9
115113
116- 10. COMBINATIONS OF GENDER –AFFIRMING
117-PROCEDURES ; AND
114+ (A) (1) IN THIS SECTION THE F OLLOWING WORDS HAVE THE MEANINGS 10
115+INDICATED. 11
118116
119- 11. OTHER TREATMENTS AS P RESCRIBED TO SUPPRES S
120-THE DEVELOPMENT OF E NDOGENOUS SECONDARY SEX CHARACTERISTICS , ALIGN
121-THE INDIVIDUAL ’S APPEARANCE OR PHYS ICAL BODY WITH GENDE R IDENTITY, AND
122-ALLEVIATE SYMPTOMS O F CLINICALLY SIGNIFICANT DISTR ESS RESULTING FROM
123-GENDER DYSPHORIA .
117+ (2) (I) “GENDER–AFFIRMING TREATMENT ” MEANS ANY 12
118+MEDICALLY NECESSARY TREATMENT CONSISTENT WITH CURRENT CLINICA L 13
119+STANDARDS OF CARE PR ESCRIBED BY A LICENS ED HEALTH CARE PROVI DER FOR 14
120+THE TREATMENT OF A C ONDITION RELATED TO THE INDIVIDU AL’S GENDER 15
121+IDENTITY. 16
124122
125- (III) “GENDER–AFFIRMING TREATMENT ” MAY INCLUDE
126-TREATMENT DESCRIBED IN THE CURRENT CLINI CAL STANDARDS OF CAR E FOR
127-GENDER–AFFIRMING TREATMENT PUBLISHED BY THE WORLD PROFESSIONAL
128-ASSOCIATION FOR TRANSGENDER HEALTH.
123+ (II) “GENDER–AFFIRMING TREATMENT ” INCLUDES: 17
129124
130- (3) “GENDER IDENTITY ” HAS THE MEANING STAT ED IN § 20–101 OF
131-THE STATE GOVERNMENT ARTICLE.
125+ 1. HORMONE THERAPY , HORMONE BLOCKERS , AND 18
126+PUBERTY BLOCKERS ; 19
132127
133- (B) IT IS THE INTENT OF T HE GENERAL ASSEMBLY THAT THE PROGRAM
134-PROVIDE GENDER –AFFIRMING TREATMENT TO ALL PROGRAM RECIPIENTS FO R
135-WHOM GENDER –AFFIRMING TREATMENT IS M EDICALLY NECESSARY , INCLUDING
136-TRANSGENDER , NONBINARY, INTERSEX, TWO–SPIRIT, AND OTHER GENDER DIV ERSE
137-INDIVIDUALS.
128+ 2. HAIR ALTERATION FOR T HE PURPOSES OF ALTER ING 20
129+SECONDARY SEX CHARAC TERISTICS AND SURGIC AL SITE PREPARATION ; 21
138130
139- (C) (1) THE PROGRAM SHALL PROVIDE COVERAGE FOR MEDICAL LY
140-NECESSARY GENDER –AFFIRMING TREATMENT IN A NONDISCRIMINATO RY MANNER. Ch. 253 2023 LAWS OF MARYLAND
131+ 3. ALTERATIONS TO VOICE , VOICE THERAPY , AND VOICE 22
132+LESSONS; 23
141133
142-– 4 –
134+ 4. ALTERATIONS TO ABDOME N, CHEST, TRUNK, AND 24
135+BUTTOCKS; 25
143136
144- (2) THE GENDER –AFFIRMING TREATMENT SHALL BE ASSESSED
145-ACCORDING TO NONDISC RIMINATORY CRITERIA THAT ARE CONSISTENT WITH
146-CURRENT CLINICAL STA NDARDS OF CARE .
137+ 5. ALTERATIONS TO THE FACE AND NECK ; 26
147138
148- (3) THE PROGRAM MAY NOT DENY OR LIMIT COVERAGE FO R
149-GENDER–AFFIRMING TREATMENT WHEN THAT TR EATMENT IS:
139+ 6. ALTERATIONS TO THE GENITALS AND GONADS; 27
150140
151- (I) PRESCRIBED TO A PROGRAM RECIPIENT BEC AUSE OF,
152-RELATED TO, OR CONSISTENT WITH T HE RECIPIENT’S GENDER IDENTITY ;
141+ 7. LASER TREATMENT FOR S CARS FROM 28
142+GENDER–AFFIRMING TREATMENT ; 29
143+ 4 HOUSE BILL 283
153144
154- (II) MEDICALLY NECESSARY ; AND
155145
156- (III) PRESCRIBED IN ACCORDA NCE WITH CURRENT CLI NICAL
157-STANDARDS OF CARE .
146+ 8. STANDARD FERTILITY PR ESERVATION PROCEDURE S, 1
147+AS SET FORTH IN § 15–810.1 OF THE INSURANCE ARTICLE; 2
158148
159- (4) THE PROGRAM MAY NOT DENY OR LIMIT COVERAGE FO R
160-GENDER–AFFIRMING TREATMENT BASED ON THE PROGRAM RECIPIENT ’S GENDER
161-IDENTITY.
149+ 9. REVISIONS TO PREVIOUS TREATMENTS AND 3
150+REVERSAL OF TREATMEN TS; 4
162151
163- (5) THE PROGRAM MAY NOT EXCLU DE GENDER –AFFIRMING
164-TREATMENT , INCLUDING REVISIONS TO PRIOR GENDER –AFFIRMING TREATMENT ,
165-ON THE BASIS TH AT THE TREATMENT IS A COSMETIC SERVICE .
152+ 10. COMBINATIONS OF GENDE R–AFFIRMING 5
153+PROCEDURES ; AND 6
166154
167- (6) THE PROGRAM MAY NOT ESTAB LISH A CATEGORICAL E XCLUSION
168-FOR A PARTICULAR GEN DER–AFFIRMING TREATMENT .
155+ 11. OTHER TREATMENTS AS P RESCRIBED TO SUPPRES S 7
156+THE DEVELOPMENT OF E NDOGENOUS SECONDARY SEX CHARACTERISTICS , ALIGN 8
157+THE INDIVIDUAL ’S APPEARANCE OR PHYS ICAL BODY WITH GENDE R IDENTITY, AND 9
158+ALLEVIATE SYMPTOMS O F CLINICALLY SIGNIFI CANT DISTRESS RESULT ING FROM 10
159+GENDER DYSPHORIA . 11
169160
170- (7) THE PROGRAM MAY NOT ISSUE AN ADVERSE BENEFIT
171-DETERMINATION DENYIN G OR LIMITING ACCESS TO GENDER–AFFIRMING
172-TREATMENT UNLESS A H EALTH CARE PROVIDER WITH EXPERIENCE PRES CRIBING
173-OR DELIVERING GENDER –AFFIRMING TREATMENT HAS REVIEWED AND CON FIRMED
174-THE APPROPRIATENESS OF THE ADVERSE BENEF IT DETERMINATION .
161+ (III) “GENDER–AFFIRMING TREATMENT ” MAY INCLUDE 12
162+TREATMENT DESCRIBED IN THE CURRENT CLINI CAL STANDARDS OF CAR E FOR 13
163+GENDER–AFFIRMING TREATMENT PUBLISHED BY THE WORLD PROFESSIONAL 14
164+ASSOCIATION FOR TRANSGENDER HEALTH. 15
175165
176- (D) (1) ON OR BEFORE DECEMBER 1 EACH YEAR, BEGINNING IN 2024,
177-EACH MANAGED CARE OR GANIZATION SHALL SUB MIT TO THE DEPARTMENT A
178-REPORT THAT INCLUDES , FOR EACH HEALTH CARE PROVIDER OFFERING
179-GENDER–AFFIRMING TREATMENT WITH WHICH THE MANAG ED CARE ORGANIZATION
180-HAS AN ACTIVE CONTRA CT AND WHO THAT CONSENTS TO THE INCLUSION :
166+ (3) “GENDER IDENTI TY” HAS THE MEANING STAT ED IN § 20–101 OF 16
167+THE STATE GOVERNMENT ARTICLE. 17
181168
182- (I) THE NAME AND LOCATION OF EACH THE HEALTH CARE
183-PROVIDER OFFERING GENDER –AFFIRMING TREATMENT WITH WHICH THE MANAG ED
184-CARE ORGANIZATION HA S AN ACTIVE CONTRACT ; AND
185- WES MOORE, Governor Ch. 253
169+ (B) IT IS THE INTENT OF T HE GENERAL ASSEMBLY THAT THE PROGRAM 18
170+PROVIDE GENDER –AFFIRMING TREATMENT TO ALL PROGRAM RECIPIENTS FO R 19
171+WHOM GENDER –AFFIRMING TREATMENT IS MEDICALLY NECESSA RY, INCLUDING 20
172+TRANSGENDER , NONBINARY, INTERSEX, TWO–SPIRIT, AND OTHER GENDER DIV ERSE 21
173+INDIVIDUALS. 22
186174
187-– 5 –
188- (II) THE TYPES OF GENDER –AFFIRMING TREATMENT PROVIDED
189-BY EACH THE HEALTH CARE PROVIDER ; AND
175+ (C) (1) THE PROGRAM SHALL PROVIDE COVERAGE FOR MEDICAL LY 23
176+NECESSARY GENDER –AFFIRMING TREATMENT IN A NONDISCRIMINATO RY MANNER. 24
190177
191- (III) WHETHER THE HEALTH CA RE PROVIDER CONSENTS TO
192-BEING PUBLICLY LISTE D AS PART OF THE DEPARTMENT ’S ANNUAL REPORT
193-REQUIRED UNDER PARAG RAPH (2) OF THIS SUBSECTION .
178+ (2) THE GENDER –AFFIRMING TREAT MENT SHALL BE ASSESS ED 25
179+ACCORDING TO NONDISC RIMINATORY CRITERIA THAT ARE CONSISTENT WITH 26
180+CURRENT CLINICAL STA NDARDS OF CARE . 27
194181
195- (2) (I) ON OR BEFORE JANUARY 1 EACH YEAR, BEGINNING IN
196-2025, THE DEPARTMENT SHALL COMP ILE AN ANNUAL REPORT ON GEOGRAPHIC
197-ACCESS TO GENDER –AFFIRMING TREATMENT ACROSS THE STATE.
182+ (3) THE PROGRAM MAY NOT DENY OR LIMIT COVERAGE FO R 28
183+GENDER–AFFIRMING TREATMENT WHEN THAT TREATMENT IS: 29
198184
199- (II) THE REPORT SHALL INCL UDE, FOR EACH HEALTH CARE
200-PROVIDER OFFERING GE NDER–AFFIRMING TREATMENT TO PROGRAM RECIPIENTS
201-AND WHOSE C ONSENT TO THE INCLUS ION IS INDICATED IN A REPORT SUBMITTED
202-UNDER PARAGRAPH (1) OF THIS SUBSECTION :
185+ (I) PRESCRIBED TO A PROGRAM RECIPIENT BECAU SE OF, 30
186+RELATED TO, OR CONSISTENT WITH T HE RECIPIENT’S GENDER IDENTITY ; 31
203187
204- 1. THE NAME AND LOCATION OF EACH THE HEALTH
205-CARE PROVIDER OFFERING GENDER –AFFIRMING TREATMENT TO PROGRAM
206-RECIPIENTS;
188+ (II) MEDICALLY NECESSARY ; AND 32
189+ HOUSE BILL 283 5
207190
208- 2. THE MANAGED CARE ORGA NIZATIONS THAT HAVE
209-ACTIVE CONTRACTS WIT H EACH THE HEALTH CARE PROVIDER ; AND
210191
211- 3. THE TYPES OF GENDER –AFFIRMING TREATMENT
212-PROVIDED BY EACH THE HEALTH CARE PROVIDER .
192+ (III) PRESCRIBED IN ACCORDA NCE WITH CURRENT CLI NICAL 1
193+STANDARDS OF CARE . 2
213194
214- (III) THE DEPARTMENT SHALL PUBL ISH THE REPORT IN A
215-CONSPICUOU S MANNER ON THE DEPARTMENT ’S WEBSITE.
195+ (4) THE PROGRAM MAY NOT DENY OR LIMIT COVERAGE FO R 3
196+GENDER–AFFIRMING TREATMENT BASED ON THE PROGRAM RECIPIENT ’S GENDER 4
197+IDENTITY. 5
216198
217- (3) THE DEPARTMENT AND EACH M ANAGED CARE ORGANIZA TION
218-SHALL INCLUDE THE NA ME, LOCATION, AND TYPES OF SERVICE S FOR EACH
219-PROVIDER OFFERING GE NDER–AFFIRMING TREATMENT IN THEIR PROVIDER
220-DIRECTORIES.
199+ (5) THE PROGRAM MAY NOT EXCLU DE GENDER –AFFIRMING 6
200+TREATMENT , INCLUDING REVISIONS TO PRIOR GENDER –AFFIRMING TREATMENT , 7
201+ON THE BASIS THAT TH E TREATMENT IS A COS METIC SERVICE. 8
221202
222- SECTION 2. AND BE IT FURTHER ENACTED, That this Act shall take effect
223-October 1, 2023.
203+ (6) THE PROGRAM MAY NOT ESTAB LISH A CATEGORICAL E XCLUSION 9
204+FOR A PARTICULAR GEN DER–AFFIRMING TREATMENT . 10
224205
225-Approved by the Governor, May 3, 2023.
206+ (7) THE PROGRAM MAY NOT ISSUE AN ADVERSE BENEFIT 11
207+DETERMINATION DENYIN G OR LIMITING ACCESS TO GENDER –AFFIRMING 12
208+TREATMENT UNLESS A H EALTH CARE PROVIDE R WITH EXPERIENCE PR ESCRIBING 13
209+OR DELIVERING GENDER –AFFIRMING TREATMENT HAS REVIEWED AND CON FIRMED 14
210+THE APPROPRIATENESS OF THE ADVERSE BENEF IT DETERMINATION . 15
211+
212+ (D) (1) ON OR BEFORE DECEMBER 1 EACH YEAR, BEGINNING IN 2024, 16
213+EACH MANAGED CARE OR GANIZATION SHALL SUBMIT TO THE DEPARTMENT A 17
214+REPORT THAT INCLUDES , FOR EACH HEALTH CARE PROVIDER OFFERING 18
215+GENDER–AFFIRMING TREATMENT WITH WHICH THE MANAG ED CARE ORGANIZATION 19
216+HAS AN ACTIVE CONTRA CT AND WHO THAT CONSENTS TO THE INCL USION: 20
217+
218+ (I) THE NAME AND LOCATION OF EACH THE HEALTH CARE 21
219+PROVIDER OFFERING GENDER –AFFIRMING TREATMENT WITH WHICH THE MANAG ED 22
220+CARE ORGANIZATION HA S AN ACTIVE CONTRACT ; AND 23
221+
222+ (II) THE TYPES OF GENDER –AFFIRMING TREATMENT PROVIDED 24
223+BY EACH THE HEALTH CARE PROVIDER ; AND 25
224+
225+ (III) WHETHER THE HEA LTH CARE PROVIDER CO NSENTS TO 26
226+BEING PUBLICLY LISTE D AS PART OF THE DEPARTMENT ’S ANNUAL REPORT 27
227+REQUIRED UNDER PARAG RAPH (2) OF THIS SUBSECTION . 28
228+
229+ (2) (I) ON OR BEFORE JANUARY 1 EACH YEAR, BEGINNING IN 29
230+2025, THE DEPARTMENT SHALL COMP ILE AN ANNUAL REPORT ON GEOGRAPHIC 30
231+ACCESS TO GENDER –AFFIRMING TREATMENT ACROSS THE STATE. 31
232+
233+ (II) THE REPORT SHALL INCL UDE, FOR EACH HEALTH CARE 32
234+PROVIDER OFFERING GE NDER–AFFIRMING TREATMENT TO PROGRAM RECIPIENTS 33 6 HOUSE BILL 283
235+
236+
237+AND WHOSE CONSENT TO THE INCLUSION IS IND ICATED IN A REPORT S UBMITTED 1
238+UNDER PARAGRAPH (1) OF THIS SUBSECTION : 2
239+
240+ 1. THE NAME AND LOCATION OF EACH THE HEALTH 3
241+CARE PROVIDER OFFERING GENDER –AFFIRMING TREATMENT TO PROGRAM 4
242+RECIPIENTS; 5
243+
244+ 2. THE MANAGED CARE ORGA NIZATIONS THAT HAVE 6
245+ACTIVE CONTRACTS WIT H EACH THE HEALTH CARE PROVIDER ; AND 7
246+
247+ 3. THE TYPES OF GENDER –AFFIRMING TREATMENT 8
248+PROVIDED BY EACH THE HEALTH CARE PROVIDER . 9
249+
250+ (III) THE DEPARTMENT SHALL PUBL ISH THE REPORT IN A 10
251+CONSPICUOUS MANNER O N THE DEPARTMENT ’S WEBSITE. 11
252+
253+ (3) THE DEPARTMENT AND EACH M ANAGED CARE ORGANIZA TION 12
254+SHALL INCLUDE THE NA ME, LOCATION, AND TYPES OF SERVICE S FOR EACH 13
255+PROVIDER OFFERING GE NDER–AFFIRMING TREATMENT IN THEIR PROVIDER 14
256+DIRECTORIES. 15
257+
258+ SECTION 2. AND BE IT FURTHER ENACTED, That this Act shall take effect 16
259+October 1, 2023. 17
260+
261+
262+
263+
264+
265+
266+Approved:
267+________________________________________________________________________________
268+ Governor.
269+________________________________________________________________________________
270+ Speaker of the House of Delegates.
271+________________________________________________________________________________
272+ President of the Senate.